Veru (VERU) Stock Forecast, Price Target & Predictions
VERU Stock Forecast
Veru stock forecast is as follows: an average price target of $4.00 (represents a 384.20% upside from VERU’s last price of $0.83) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
VERU Price Target
The average price target for Veru (VERU) is $4.00 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $3.00. This represents a potential 384.20% upside from VERU's last price of $0.83.
VERU Analyst Ratings
According to 7 Wall Street analysts, Veru's rating consensus is 'Buy'. The analyst rating breakdown for VERU stock is 0 'Strong Buy' (0.00%), 5 'Buy' (71.43%), 2 'Hold' (28.57%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Veru Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 03, 2024 | Yi Chen | H.C. Wainwright | $3.00 | $1.67 | 79.64% | 263.15% |
| Apr 15, 2024 | Leland Gershell | Oppenheimer | $5.00 | $1.52 | 228.95% | 505.25% |
| Dec 07, 2022 | - | H.C. Wainwright | $18.00 | $5.66 | 218.02% | 2078.91% |
| Apr 15, 2022 | Leland Gershell | Oppenheimer | $36.00 | $14.95 | 140.80% | 4257.83% |
The latest Veru stock forecast, released on May 03, 2024 by Yi Chen from H.C. Wainwright, set a price target of $3.00, which represents a 79.64% increase from the stock price at the time of the forecast ($1.67), and a 263.15% increase from VERU last price ($0.83).
Veru Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $4.00 |
| Last Closing Price | $0.83 | $0.83 | $0.83 |
| Upside/Downside | -100.00% | -100.00% | 384.20% |
In the current month, the average price target of Veru stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Veru's last price of $0.83. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 14, 2024 | B. Riley | - | Buy | Initialise |
| May 06, 2024 | Raymond James | Buy | Buy | Hold |
| May 03, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Apr 15, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Jun 07, 2023 | Jefferies | Buy | Hold | Upgrade |
| Dec 05, 2022 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Jul 11, 2022 | Oppenheimer | Outperform | Outperform | Hold |
| Jul 06, 2022 | Jefferies | Buy | Buy | Hold |
| May 13, 2022 | Oppenheimer | Outperform | Outperform | Hold |
| May 13, 2022 | Jefferies | Buy | Buy | Hold |
Veru's last stock rating was published by B. Riley on May 14, 2024. The company Initialise its VERU rating from "null" to "Buy".
Veru Financial Forecast
Veru Revenue Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $2.14M | $3.86M | $3.34M | $6.59M | $2.51M | $2.59M | $9.60M | $13.03M | $14.14M | $15.65M | $17.66M | $13.34M | $14.62M | $11.75M | $10.32M | $9.94M | $10.58M | $8.73M | $9.73M | $6.98M |
| Avg Forecast | $1.70M | $1.90M | $2.10M | $2.95M | $3.02M | $3.10M | $3.17M | $3.56M | $3.50M | $3.00M | $3.90M | $3.95M | $6.21M | $4.33M | $5.07M | $11.55M | $16.67M | $12.21M | $13.84M | $18.17M | $14.10M | $14.29M | $10.92M | $10.61M | $10.74M | $10.97M | $8.77M | $9.17M | $8.06M | $6.86M |
| High Forecast | $2.05M | $2.29M | $2.54M | $3.56M | $3.65M | $3.74M | $3.83M | $4.30M | $4.23M | $3.62M | $5.90M | $4.77M | $7.51M | $5.22M | $6.12M | $13.95M | $20.13M | $14.75M | $16.72M | $21.94M | $17.03M | $17.26M | $13.19M | $12.81M | $12.97M | $13.25M | $10.59M | $11.08M | $9.73M | $8.28M |
| Low Forecast | $1.43M | $1.60M | $1.77M | $2.49M | $2.55M | $2.61M | $2.68M | $3.00M | $2.95M | $2.53M | $1.90M | $3.33M | $5.24M | $3.64M | $4.27M | $9.73M | $14.05M | $10.29M | $11.66M | $15.31M | $11.88M | $12.04M | $9.20M | $8.94M | $9.05M | $9.25M | $7.39M | $7.73M | $6.79M | $5.78M |
| # Analysts | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.55% | 0.98% | 0.54% | 1.52% | 0.49% | 0.22% | 0.58% | 1.07% | 1.02% | 0.86% | 1.25% | 0.93% | 1.34% | 1.11% | 0.96% | 0.91% | 1.21% | 0.95% | 1.21% | 1.02% |
Veru's average Quarter revenue forecast for Mar 24 based on 1 analysts is $3.00M, with a low forecast of $2.53M, and a high forecast of $3.62M. VERU's average Quarter revenue forecast represents a 40.14% increase compared to the company's last Quarter revenue of $2.14M (Dec 23).
Veru EBITDA Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | $-8.80M | $-11.84M | $4.86M | $-31.62M | $-35.59M | $-44.67M | $-21.70M | $-11.72M | $-4.85M | $-1.81M | $-2.87M | $-1.49M | $767.35K | $2.88M | $-1.33M | $-131.91K | $-1.66M | $-1.32M | $-1.70M | $-1.98M |
| Avg Forecast | $-998.88K | $-1.12M | $-1.23M | $-1.73M | $-1.78M | $-1.82M | $-1.87M | $-2.09M | $-2.06M | $-1.76M | $-2.29M | $-2.32M | $-3.65M | $-2.54M | $-2.98M | $-6.79M | $-9.79M | $-1.70M | $-8.13M | $-10.67M | $-8.29M | $-1.54M | $-6.42M | $-6.23M | $-6.31M | $530.91K | $-5.15M | $-5.39M | $-4.73M | $-2.63M |
| High Forecast | $-841.75K | $-940.78K | $-1.04M | $-1.46M | $-1.50M | $-1.53M | $-1.57M | $-1.76M | $-1.73M | $-1.49M | $-1.12M | $-1.96M | $-3.08M | $-2.14M | $-2.51M | $-5.72M | $-8.25M | $-1.36M | $-6.85M | $-9.00M | $-6.98M | $-1.24M | $-5.41M | $-5.25M | $-5.32M | $637.09K | $-4.34M | $-4.54M | $-3.99M | $-2.11M |
| Low Forecast | $-1.21M | $-1.35M | $-1.49M | $-2.09M | $-2.15M | $-2.20M | $-2.25M | $-2.53M | $-2.48M | $-2.13M | $-3.46M | $-2.80M | $-4.41M | $-3.07M | $-3.60M | $-8.20M | $-11.83M | $-2.04M | $-9.82M | $-12.89M | $-10.01M | $-1.85M | $-7.75M | $-7.53M | $-7.62M | $424.73K | $-6.22M | $-6.51M | $-5.72M | $-3.16M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 3.84% | 5.10% | -1.33% | 12.44% | 11.95% | 6.58% | 2.22% | 6.89% | 0.60% | 0.17% | 0.35% | 0.97% | -0.12% | -0.46% | 0.21% | -0.25% | 0.32% | 0.25% | 0.36% | 0.75% |
1 analysts predict VERU's average Quarter EBITDA for Sep 23 to be $-2.32M, with a high of $-1.96M and a low of $-2.80M. This is -147.76% lower than Veru's previous annual EBITDA (Jun 23) of $4.86M.
Veru Net Income Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | $-8.28M | $-23.77M | $6.31M | $-38.79M | $-36.84M | $-41.02M | $-22.20M | $-14.18M | $-6.38M | $-4.29M | $-2.69M | $-2.85M | $17.23M | $-11.83M | $-3.03M | $-810.51K | $-3.31M | $-3.06M | $-2.77M | $-4.03M |
| Avg Forecast | $-14.64M | $-13.17M | $-11.71M | $-10.61M | $-10.25M | $-10.25M | $-10.98M | $-13.07M | $-8.49M | $-7.81M | $-17.57M | $-34.40M | $-29.76M | $-48.67M | $-55.14M | $-44.28M | $-23.42M | $-3.13M | $-13.76M | $-13.47M | $-8.78M | $-2.85M | $-6.95M | $-5.37M | $-4.76M | $-1.28M | $-3.42M | $-7.32M | $-6.34M | $-4.03M |
| High Forecast | $-11.64M | $-10.48M | $-9.32M | $-8.44M | $-8.15M | $-8.15M | $-8.73M | $-12.38M | $-6.75M | $-6.21M | $-10.81M | $-27.36M | $-23.68M | $-38.72M | $-43.86M | $-35.23M | $-18.63M | $-2.50M | $-10.95M | $-10.71M | $-6.99M | $-2.28M | $-5.53M | $-4.27M | $-3.78M | $-1.02M | $-2.72M | $-5.82M | $-5.05M | $-3.23M |
| Low Forecast | $-18.59M | $-16.73M | $-14.88M | $-13.48M | $-13.02M | $-13.02M | $-13.95M | $-13.76M | $-10.78M | $-9.92M | $-20.27M | $-43.70M | $-37.81M | $-61.82M | $-70.04M | $-56.25M | $-29.75M | $-3.76M | $-17.48M | $-17.11M | $-11.16M | $-3.42M | $-8.83M | $-6.82M | $-6.04M | $-1.53M | $-4.34M | $-9.30M | $-8.06M | $-4.84M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.47% | 0.69% | -0.21% | 0.80% | 0.67% | 0.93% | 0.95% | 4.53% | 0.46% | 0.32% | 0.31% | 1.00% | -2.48% | 2.20% | 0.64% | 0.63% | 0.97% | 0.42% | 0.44% | 1.00% |
Veru's average Quarter net income forecast for Sep 23 is $-34.40M, with a range of $-43.70M to $-27.36M. VERU's average Quarter net income forecast represents a -644.80% decrease compared to the company's last Quarter net income of $6.31M (Jun 23).
Veru SG&A Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | $8.30M | $6.77M | $10.90M | $12.83M | $17.55M | $18.29M | $10.76M | $7.40M | $6.72M | $5.92M | $5.56M | $4.81M | $4.38M | $3.46M | $3.48M | $3.81M | $3.75M | $3.69M | $3.55M | $3.82M |
| Avg Forecast | $1.76M | $1.97M | $2.17M | $3.05M | $3.13M | $3.21M | $3.29M | $3.68M | $3.62M | $3.10M | $4.04M | $4.09M | $6.43M | $4.48M | $5.24M | $11.95M | $17.25M | $5.29M | $14.33M | $18.80M | $14.59M | $4.81M | $11.30M | $10.98M | $11.11M | $5.99M | $9.07M | $9.49M | $8.34M | $3.82M |
| High Forecast | $2.13M | $2.38M | $2.63M | $3.69M | $3.78M | $3.88M | $3.97M | $4.45M | $4.38M | $3.75M | $6.10M | $4.94M | $7.77M | $5.41M | $6.33M | $14.44M | $20.84M | $6.35M | $17.30M | $22.71M | $17.63M | $5.77M | $13.65M | $13.26M | $13.42M | $7.19M | $10.96M | $11.47M | $10.07M | $4.59M |
| Low Forecast | $1.48M | $1.66M | $1.83M | $2.57M | $2.64M | $2.70M | $2.77M | $3.10M | $3.05M | $2.62M | $1.97M | $3.45M | $5.42M | $3.77M | $4.42M | $10.07M | $14.54M | $4.23M | $12.07M | $15.85M | $12.30M | $3.85M | $9.52M | $9.25M | $9.36M | $4.80M | $7.65M | $8.00M | $7.03M | $3.06M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 2.06% | 1.66% | 1.70% | 2.87% | 3.35% | 1.53% | 0.62% | 1.40% | 0.47% | 0.32% | 0.38% | 1.00% | 0.39% | 0.32% | 0.31% | 0.63% | 0.41% | 0.39% | 0.43% | 1.00% |
Veru's average Quarter SG&A projection for Mar 24 is $3.10M, based on 1 Wall Street analysts, with a range of $2.62M to $3.75M. The forecast indicates a -62.60% fall compared to VERU last annual SG&A of $8.30M (Dec 23).
Veru EPS Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | $-0.08 | $-0.28 | $0.07 | $-0.48 | $-0.46 | $-0.51 | $-0.28 | $-0.18 | $-0.08 | $-0.05 | $-0.03 | $-0.04 | $0.25 | $-0.17 | $-0.05 | $-0.01 | $-0.05 | $-0.05 | $-0.04 | $-0.06 |
| Avg Forecast | $-0.10 | $-0.09 | $-0.08 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | $-0.09 | $-0.06 | $-0.05 | $-0.12 | $-0.23 | $-0.20 | $-0.33 | $-0.38 | $-0.30 | $-0.16 | $-0.14 | $-0.09 | $-0.09 | $-0.06 | $-0.04 | $-0.05 | $-0.04 | $-0.03 | $-0.04 | $-0.02 | $-0.05 | $-0.04 | $-0.06 |
| High Forecast | $-0.08 | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.06 | $-0.06 | $-0.08 | $-0.05 | $-0.04 | $-0.07 | $-0.19 | $-0.16 | $-0.26 | $-0.30 | $-0.24 | $-0.13 | $-0.11 | $-0.07 | $-0.07 | $-0.05 | $-0.03 | $-0.04 | $-0.03 | $-0.03 | $-0.03 | $-0.02 | $-0.04 | $-0.03 | $-0.05 |
| Low Forecast | $-0.13 | $-0.11 | $-0.10 | $-0.09 | $-0.09 | $-0.09 | $-0.10 | $-0.09 | $-0.07 | $-0.07 | $-0.14 | $-0.30 | $-0.26 | $-0.42 | $-0.48 | $-0.38 | $-0.20 | $-0.18 | $-0.12 | $-0.12 | $-0.08 | $-0.05 | $-0.06 | $-0.05 | $-0.04 | $-0.05 | $-0.03 | $-0.06 | $-0.06 | $-0.07 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.69% | 1.19% | -0.35% | 1.44% | 1.22% | 1.69% | 1.75% | 1.27% | 0.85% | 0.58% | 0.56% | 1.00% | -5.26% | 4.64% | 1.39% | 0.29% | 2.18% | 0.94% | 1.02% | 1.12% |
According to 1 Wall Street analysts, Veru's projected average Quarter EPS for Sep 23 is $-0.23, with a low estimate of $-0.30 and a high estimate of $-0.19. This represents a -428.67% decrease compared to VERU previous annual EPS of $0.07 (Jun 23).
Veru Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals | $1.70 | $10.00 | 488.24% | Buy |
| NVAX | Novavax | $13.61 | $74.67 | 448.64% | Buy |
| VERU | Veru | $0.83 | $4.00 | 381.93% | Buy |
| ANVS | Annovis Bio | $8.01 | $23.50 | 193.38% | Buy |
| IOVA | Iovance Biotherapeutics | $10.34 | $21.57 | 108.61% | Buy |
| AVXL | Anavex Life Sciences | $5.31 | $11.00 | 107.16% | Buy |
| SRPT | Sarepta Therapeutics | $124.65 | $169.93 | 36.33% | Buy |
| AXSM | Axsome Therapeutics | $93.67 | $117.83 | 25.79% | Buy |
| MCRB | Seres Therapeutics | $1.00 | $1.25 | 25.00% | Buy |
| TSVT | 2seventy bio | $4.71 | $2.00 | -57.54% | Buy |
VERU Forecast FAQ
Is Veru a good buy?
Yes, according to 7 Wall Street analysts, Veru (VERU) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 71.43% of VERU's total ratings.
What is VERU's price target?
Veru (VERU) average price target is $4 with a range of $3 to $5, implying a 384.20% from its last price of $0.826. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Veru stock go up soon?
According to Wall Street analysts' prediction for VERU stock, the company can go up by 384.20% (from the last price of $0.826 to the average price target of $4), up by 505.25% based on the highest stock price target, and up by 263.15% based on the lowest stock price target.
Can Veru stock reach $1?
VERU's average twelve months analyst stock price target of $4 supports the claim that Veru can reach $1 in the near future.
What are Veru's analysts' financial forecasts?
Veru's analysts financial forecasts for the fiscal year (Sep 2024) are as follows: average revenue is $13.96M (high $18.05M, low $10.38M), average EBITDA is $-8.203M (high $-6.1M, low $-10.604M), average net income is $-46.933M (high $-36.154M, low $-54.729M), average SG&A $14.45M (high $18.68M, low $10.75M), and average EPS is $-0.321 (high $-0.247, low $-0.374). VERU's analysts financial forecasts for the fiscal year (Sep 2025) are as follows: average revenue is $12.25M (high $14.8M, low $10.32M), average EBITDA is $-7.198M (high $-6.066M, low $-8.694M), average net income is $-42.085M (high $-33.479M, low $-53.458M), average SG&A $12.68M (high $15.31M, low $10.68M), and average EPS is $-0.288 (high $-0.229, low $-0.365).
Did the VERU's actual financial results beat the analysts' financial forecasts?
Based on Veru's last annual report (Sep 2022), the company's revenue was $39.35M, which missed the average analysts forecast of $54.27M by -27.48%. Apple's EBITDA was $-83.224M, beating the average prediction of $-26.412M by 215.09%. The company's net income was $-83.776M, missing the average estimation of $-84.593M by -0.97%. Apple's SG&A was $43.17M, missing the average forecast of $48.82M by -11.57%. Lastly, the company's EPS was $-1.05, beating the average prediction of $-0.699 by 50.32%. In terms of the last quarterly report (Dec 2023), Veru's revenue was $2.14M, missing the average analysts' forecast of $3.9M by -45.11%. The company's EBITDA was $-8.801M, beating the average prediction of $-2.292M by 284.06%. Veru's net income was $-8.276M, missing the average estimation of $-17.566M by -52.89%. The company's SG&A was $8.3M, beating the average forecast of $4.04M by 105.67%. Lastly, the company's EPS was $-0.0823, missing the average prediction of $-0.12 by -31.42%